Paula Soria-Chacartegui

14PUBLICATIONS
33CO-AUTHORS
PharmacogenomicsGenome structure and regulationMajor global burdens of diseaseGene expression (incl. microarray and other genome-wide approaches)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 03, 2026
Role of Pharmacogenetics on Tramadol Pharmacokinetics: A Population Pharmacokinetic Model.

Paula Soria-Chacartegui, Gudrun Würthwein, Pablo Zubiaur

|Jan 11, 2025
Effect of Genetic Variants on Rosuvastatin Pharmacokinetics in Healthy Volunteers: Involvement of ABCG2, SLCO1B1 and NAT2.

Eva González-Iglesias, Clara Méndez-Ponce, Dolores Ochoa

|Aug 29, 2024
Genetic Variation in CYP2D6, UGT1A4, SLC6A2 and SLCO1B1 Alters the Pharmacokinetics and Safety of Mirabegron.

Paula Soria-Chacartegui, Patricia Cendoya-Ramiro, Eva González-Iglesias

|Apr 13, 2024
Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis.

Paula Soria-Chacartegui, Marcos Navares-Gómez, Francisca Molina-Jiménez

|Dec 23, 2023
Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain.

Ana Casajús, Pablo Zubiaur, Enrique Alday

|Aug 01, 2023
Impact of CYP2C:TG Haplotype on CYP2C19 Substrates Clearance In Vivo, Protein Content, and In Vitro Activity.

Pablo Zubiaur, Paula Soria-Chacartegui, Erin C Boone

Pageof 3

Frequent Collaborators

14 joint publications

Francisco Abad-Santos

12 joint publications

Pablo Zubiaur

9 joint publications

Gonzalo Villapalos-García

7 joint publications

Gina Mejía-Abril